Latest Corporate & Commercial Updates

Latest Press releases

Veracyte Completes Acquisition of HalioDx

Fuels growth by enabling IVD test development and manufacturing for nCounter diagnostic platform

Expands scientific...

 Read more

HalioDx and Veracyte set proposed acquisition terms

French version available (pdf)

 Read more

Immunoscore® is now available in Rectal Cancer for expert clinical centers through an Innovation Access Program

  • Immunoscore® heads up to become the standard precision tool for the “Watch and Wait” strategy in locally advanced...

 Read more

IMMUNOSCORE® in Colon Cancer

HalioDx Partners with DASA, the Largest Diagnostics Provider in Latin America, to make Immunoscore® available in Brazil

HalioDx SAS, the immuno-oncology diagnostic company pioneering the immunological diagnosis of cancers, today announced...

 Read more

Distributors

Expanding Immunoscore® clinical utility on 3000+ stage III colon cancer patients

HalioDx SAS, the immuno-oncology diagnostic company pioneering the immunological diagnosis of cancers, today announced...

 Read more

IMMUNOSCORE® in Colon Cancer

New data reinforce Immunoscore® clinical utility in localized Colon Cancer

  • Changes in patterns of oncology care with the incorporation of immune response in a study of Stage II colon cancer...
 Read more

Paltown Development Foundation and HalioDx Team Up for Colorectal Cancer Testing Center

COLONTOWN University Launches Secure Platform for Colorectal Cancer Patients

HalioDx SAS, the immuno-oncology...

 Read more

IMMUNOSCORE® in Colon Cancer

Jérôme Galon has been awarded the French the Legion of Honor, or "Legion d'Honneur", received today from Gilles Bloch, Chairman and Chief Executive Officer of Inserm

Read more

See more Press releases